Clearside Biomedical (CLSD) News Today → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free CLSD Stock Alerts $1.34 +0.08 (+6.35%) (As of 05:27 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCLSD Clearside Biomedical, Inc.seekingalpha.com - April 21 at 9:52 AMClearside Biomedical, Inc. (NASDAQ:CLSD) Given Consensus Recommendation of "Buy" by Analystsamericanbankingnews.com - April 17 at 2:34 AMClearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directorsglobenewswire.com - April 16 at 7:05 AMClearside Biomedical, Inc. (NASDAQ:CLSD) Sees Significant Drop in Short Interestmarketbeat.com - April 15 at 12:39 AMClearside Biomedical (NASDAQ:CLSD) Stock Rating Reaffirmed by Needham & Company LLCmarketbeat.com - April 11 at 8:26 AMClearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conferenceglobenewswire.com - April 2 at 7:05 AMShort Interest in Clearside Biomedical, Inc. (NASDAQ:CLSD) Expands By 23.4%marketbeat.com - March 30 at 3:59 PMNgai Hang Victor Chong Buys 30,000 Shares of Clearside Biomedical, Inc. (NASDAQ:CLSD) Stockinsidertrades.com - March 21 at 10:32 AMInsider Buying: Clearside Biomedical, Inc. (NASDAQ:CLSD) Insider Buys 30,000 Shares of Stockmarketbeat.com - March 20 at 7:54 PMHC Wainwright Reiterates "Buy" Rating for Clearside Biomedical (NASDAQ:CLSD)marketbeat.com - March 18 at 4:33 PMClearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officerglobenewswire.com - March 18 at 7:05 AMClearside Biomedical, Inc. (NASDAQ:CLSD) Short Interest Up 70.1% in Februarymarketbeat.com - March 14 at 10:30 PMClearside Biomedical: Strong Buy Rating on Robust Financials and Clinical Trial Progressmarkets.businessinsider.com - March 14 at 6:55 PMClearside Biomedical Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Linefinance.yahoo.com - March 14 at 8:15 AMBuy Rating Affirmed for Clearside Biomedical on Innovative Treatments and Strong Financialsmarkets.businessinsider.com - March 13 at 10:44 AMClearside Biomedical, Inc. (NASDAQ:CLSD) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 13 at 10:44 AMClearside Biomedical (NASDAQ:CLSD) Given "Outperform" Rating at Wedbushmarketbeat.com - March 13 at 10:27 AMClearside Biomedical: Q4 Earnings Insightsbenzinga.com - March 12 at 11:20 PMClearside Biomedical Inc (CLSD) Reports Significant Licensing Revenue Growth in Q4 and Full ...finance.yahoo.com - March 12 at 6:20 PMClearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updateglobenewswire.com - March 12 at 4:05 PMPreview: Clearside Biomedical's Earningsbenzinga.com - March 11 at 4:11 PMClearside Biomedical, Inc. (CLSD)finance.yahoo.com - March 1 at 7:35 PMClearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024globenewswire.com - February 29 at 7:05 AM7 Biotech Penny Stocks on the Verge of Clinical Trial Victoryinvestorplace.com - February 25 at 1:37 PMModivCare is about to announce its earnings — here's what Wall Street expectsmarkets.businessinsider.com - February 21 at 11:53 PMClearside Biomedical Stock (NASDAQ:CLSD), Short Interest Reportbenzinga.com - February 21 at 6:53 PMCLSD Apr 2024 5.000 callfinance.yahoo.com - February 18 at 11:28 PMClearside Biomedical (NASDAQ:CLSD) Raised to "Hold" at StockNews.commarketbeat.com - February 10 at 1:32 AMClearside Biomedical, Inc. (NASDAQ:CLSD) Major Shareholder Buys $599,999.40 in Stockmarketbeat.com - February 9 at 3:24 PMClearside Biomedical Launches $15M Direct Offeringmsn.com - February 9 at 10:51 AMClearside Biomedical Announces Registered Direct Offering Pricingmsn.com - February 9 at 10:51 AMPleasing Signs As A Number Of Insiders Buy Clearside Biomedical Stockfinance.yahoo.com - February 9 at 10:51 AMClearside Biomedical Announces Pricing of $15 Million Registered Direct Offeringfinance.yahoo.com - February 7 at 1:46 PMClearside Biomedical, Inc. (NASDAQ:CLSD) Receives Consensus Recommendation of "Buy" from Brokeragesmarketbeat.com - February 2 at 1:36 AMClearside Biomedical (NASDAQ:CLSD) Rating Lowered to Sell at StockNews.commarketbeat.com - February 2 at 1:26 AMBuy Rating Affirmed for Clearside Biomedical Amidst Strong Clinical Progress and Strategic Partnershipsmarkets.businessinsider.com - December 15 at 5:44 PMClearside Biomedical, Inc.: Clearside Biomedical Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMDfinanznachrichten.de - December 14 at 10:24 AMClearside Biomedical reports progress in ODYSSEY Phase 2b trial of CLS-AXmsn.com - December 14 at 10:24 AMCan Clearside Biomedical (NASDAQ:CLSD) Afford To Invest In Growth?finance.yahoo.com - December 6 at 2:06 PMClearside Biomedical, Inc.: Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - November 23 at 9:35 AMClearside Biomedical Earns Buy Rating Amid Successful Clinical Trials and Promising Partnerships: An Analysis by Jonathan Wollebenmarkets.businessinsider.com - November 15 at 7:57 AMPromising Developments and Financial Stability Bolster Buy Rating for Clearside Biomedicalmarkets.businessinsider.com - November 14 at 9:57 PMClearside Biomedical, Inc. (NASDAQ:CLSD) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 14 at 11:56 AMClearside Biomedical: Q3 Earnings Insightsbenzinga.com - November 13 at 5:24 PMClearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - November 13 at 5:24 PMClearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - November 13 at 5:24 PMClearside Biomedical Q3 2023 Earnings Previewmsn.com - November 12 at 8:50 PMClearside Biomedical to Participate in Fireside Chat at the Stifel 2023 Healthcare Conferencefinance.yahoo.com - November 8 at 12:06 PMClearside Biomedical’s Versatile Suprachoroidal Injection Platform Highlighted in Four Ophthalmic Indications in Clinical Data Presentations at AAO 2023 Annual Meetingfinance.yahoo.com - November 7 at 9:06 PMClearside Biomedical Receives Buy Rating Based on Promising Developments and Potential Market Opportunitiesmarkets.businessinsider.com - November 6 at 7:50 PM Get Clearside Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for CLSD and its competitors with MarketBeat's FREE daily newsletter. Email Address Move Your Money Before May 22 (Ad)The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. CLSD Media Mentions By Week CLSD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLSD News Sentiment▼0.000.32▲Average Medical News Sentiment CLSD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLSD Articles This Week▼21▲CLSD Articles Average Week Get Clearside Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for CLSD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Aclaris Therapeutics News Today PMV Pharmaceuticals News Today Chimerix News Today BioXcel Therapeutics News Today Eton Pharmaceuticals News Today DiaMedica Therapeutics News Today Oncolytics Biotech News Today Affimed News Today Hookipa Pharma News Today Allakos News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CLSD) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithMan Who Predicted 2008: “This Will be Worse.”AltimetryFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearside Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
